Keystone Symposia, Innate and Non-Classical Immune Cells in Cancer Immunotherapy (C5) | Keystone, USA

Thursday, March 28 8:00 - 11:00 NK Cells and ILCs Inhibitory NK Cells Receptors in Cancer Prognosis and Therapeutic Intervention Eric Vivier, Directeur Scientifique, Innate Pharma See the full program on Keystone Symposia website.